These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6091579)

  • 41. Effects of tifluadom on passive avoidance behaviour in DBA/2 mice.
    Pavone F; Castellano C
    Behav Brain Res; 1985 May; 15(3):177-81. PubMed ID: 2988580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tifluadom-induced diuresis in rats. Evidence for an opioid receptor-mediated central action.
    Shearman GT; Tolcsvai L
    Neuropharmacology; 1986 Aug; 25(8):853-6. PubMed ID: 3022178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tifluadom (KC 5103) induces suppression and latency changes on somatosensory evoked potentials which are reversed by opioid antagonists.
    Freye E; Hartung E; Schenk GK
    Life Sci; 1983; 33 Suppl 1():537-40. PubMed ID: 6319908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kappa-opiate-induced diuresis and changes in blood pressure: demonstration of receptor stereoselectivity using (+)- and (-)-tifluadom.
    Ureta H; López LF; Pérez A; Huidobro-Toro JP
    Eur J Pharmacol; 1987 Mar; 135(3):289-95. PubMed ID: 3034631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reverse stereoselectivity of opiate and benzodiazepine receptors for the opioid benzodiazepine tifluadom.
    Kley H; Scheidemantel U; Bering B; Müller WE
    Eur J Pharmacol; 1983 Mar; 87(4):503-4. PubMed ID: 6303803
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparisons of the influence of morphine sulphate, morphine-3-glucuronide and tifluadom on social encounters in mice.
    Benton D; Smoothy R; Brain PF
    Physiol Behav; 1985 Nov; 35(5):689-93. PubMed ID: 3001798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genotype and test experience determine responsiveness to morphine.
    Collins RL; Whitney G
    Psychopharmacology (Berl); 1978 Jan; 56(1):57-60. PubMed ID: 415328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strain dependent effects of ketamine on locomotor activity and antinociception in mice.
    Filibeck U; Castellano C
    Pharmacol Biochem Behav; 1980 Sep; 13(3):443-7. PubMed ID: 7422699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An ethological analysis of the effects of tifluadom on social encounters in male albino mice.
    Brain PF; Smoothy R; Benton D
    Pharmacol Biochem Behav; 1985 Dec; 23(6):979-85. PubMed ID: 3001788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potent inhibition of non-opioid defeat analgesia in male mice by benzodiazepine antagonist Ro15-3505.
    Rodgers RJ; Randall JI
    Physiol Behav; 1988; 42(5):461-4. PubMed ID: 3393607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tifluadom's effects under electric shock titration and tail-immersion procedures in squirrel monkeys.
    Genovese RF; Dykstra LA
    Life Sci; 1986 Nov; 39(19):1713-9. PubMed ID: 3773641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different effects of apomorphine on locomotor activity in C57BL/6 and DBA/2 mice.
    Sansone M; Ammassari-Teule M; Renzi P; Oliverio A
    Pharmacol Biochem Behav; 1981 May; 14(5):741-3. PubMed ID: 7243849
    [No Abstract]   [Full Text] [Related]  

  • 53. Analgesic activity as determined by the Nilsen method.
    Perrine TD; Atwell L; Tice IB; Jacobson AE; May EL
    J Pharm Sci; 1972 Jan; 61(1):86-8. PubMed ID: 5058651
    [No Abstract]   [Full Text] [Related]  

  • 54. Physicochemical profile of tifluadom, an opioid 1,4-benzodiazepine.
    Fernandez-Arciniega MA; Hernandez L
    Boll Chim Farm; 1984 Oct; 123(10):483-8. PubMed ID: 6529491
    [No Abstract]   [Full Text] [Related]  

  • 55. An observational analysis of the effect of the selective kappa opioid agonist, U-50,488H, on feeding and related behaviours in the rat.
    Jackson A; Cooper SJ
    Psychopharmacology (Berl); 1986; 90(2):217-21. PubMed ID: 3024197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Observational analysis of the effects of kappa opioid agonists an open field behaviour in the rat.
    Jackson A; Cooper SJ
    Psychopharmacology (Berl); 1988; 94(2):248-53. PubMed ID: 2895484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opioids and behavior: genetic aspects.
    Frischknecht HR; Siegfried B; Waser PG
    Experientia; 1988 Jun; 44(6):473-81. PubMed ID: 2837410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain mu and delta opioid receptors mediate different locomotor hyperactivity responses of the C57BL/6J mouse.
    Mickley GA; Mulvihill MA; Postler MA
    Psychopharmacology (Berl); 1990; 101(3):332-7. PubMed ID: 2163538
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Locomotor depression by the opioid benzodiazepine tifluadom in mice.
    Castellano C; Pavone F; Sansone M
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):318-23. PubMed ID: 6091579
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of kappa-opioid receptor agonists on locomotor activity and memory processes in mice.
    Castellano C; Ammassari-Teule M; Libri V; Pavone F
    Pol J Pharmacol Pharm; 1988; 40(5):507-13. PubMed ID: 2855367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.